Wellcome's bold ambitions to improve health through our new strategy
We've introduced a new vision and strategy for Wellcome that we hope will have significant positive impacts on the course of human health over the next two decades.
We need Covid-19 treatments as well as vaccines – and they have to work for everyone
Effective treatments, that are accessible to everyone who needs them, have to be part of the solution to the coronavirus pandemic – here's why.
Once we have effective Covid-19 treatments, it shouldn’t only be the rich who benefit
We need a range of treatments to make Covid-19 preventable and treatable. Jeremy Farrar describes recent progress made by research and why more investment is needed.
More people should have access to monoclonal antibodies. Covid-19 can make that happen
Monoclonal antibodies, one of the most promising treatments for Covid-19, are usually expensive and not available worldwide. Lindsay Keir highlights what needs to be done to change that.
How can we get effective treatments for Covid-19?
From repurposed drugs to new therapies – researchers are working at incredible speed to find the best ways to treat Covid-19 patients.
To make the charity sector safe for everyone, we need to Speak Up
We know that in the charity sector it can be difficult for colleagues to challenge bad practice. That’s why we’ve developed Speak Up – a new initiative to help us build a real culture of trust.
What are monoclonal antibodies – and can they treat Covid-19?
For more than 30 years, monoclonal antibodies have transformed the way we treat many diseases. Researchers think they are also one of the most promising treatments for Covid-19. Here's why.
Covid-19 in the UK: the hard choices we face
Six months after lockdown was first announced in the UK, the country is seeing a rise in Covid-19 infections. Jeremy Farrar reflects on the measures we need to suppress transmission.
What’s next for COVID-Zero?
Wellcome launched COVID-Zero in April to mobilise urgent donations from businesses and philanthropists for Covid-19 research. As we draw the campaign to a close, Mark Henderson discusses what it has achieved.
What are human infection studies and why do we need them?
Human infection studies have the power to rapidly accelerate the development of much-needed vaccines and treatments, including for Covid-19.
Covid-19: what’s good for public health is also good for the economy
Covid-19 is exacerbating existing health, economic and social inequalities in the US and across the world. Claude Lopez explains why investing in coronavirus treatment research and development is an imperative for business leaders and philanthropists.
From equality to global poverty: how Covid-19 is affecting societies and economies
The Covid-19 pandemic is a social and an economic crisis just as much as it is a health crisis – its repercussions, severe and far-reaching, are being felt across the world.